Pharmacotherapy with immunotherapy for the treatment of otolaryngic allergy.
作者信息
Mabry R L
机构信息
Department of Otorhinolaryngology, University of Texas Southwestern Medical Center, Dallas.
出版信息
Ear Nose Throat J. 1990 Jan;69(1):63-71.
PMID:1968002
Abstract
The total management of the patient with inhalant nasal allergy involves the triad of environmental control, pharmacotherapy, and immunotherapy. The latter treatment may not be necessary in all cases, but definitive testing for the responsible allergens may allow proper avoidance measures. Pharmacotherapy and immunotherapy are complementary, not mutually exclusive, and are a major part of the therapeutic armamentarium of the allergist.
摘要
相似文献
1
Pharmacotherapy with immunotherapy for the treatment of otolaryngic allergy.
Ear Nose Throat J. 1990 Jan;69(1):63-71.
2
[The treatment of allergic diseases].
Union Med Can. 1985 Jan;114(1):41-5.
3
Otolaryngic allergy.耳鼻喉科过敏
Otolaryngol Clin North Am. 1993 Aug;26(4):593-611.
4
Therapy for allergic rhinitis.变应性鼻炎的治疗
Compr Ther. 1985 Jun;11(6):60-9.
5
Intranasal therapy in hay fever.
Aust Fam Physician. 1980 Nov;9(11):794-803.
6
[Supplementary therapeutics in allergology].
Soins. 1980 Mar 20;25(6):43-5.
7
Pharmacology of allergic eye disease.过敏性眼病的药理学
J Am Optom Assoc. 1990 Jun;61(6 Suppl):S23-31.
8
New thinking on the treatment of rhinitis.
Practitioner. 1997 May;241(1574):286-90.
9
Drugs used in the treatment of pediatric allergy and asthma.
Pediatr Nurs. 1977 Mar-Apr;3(2):12-5.
10
Hay fever: pharmacotherapy or immunotherapy?花粉症：药物治疗还是免疫治疗？
J S C Med Assoc. 1994 Oct;90(10):499-500.
引用本文的文献
1
Human Immunodeficiency Virus 1 Preferentially Fuses with pH-Neutral Endocytic Vesicles in Cell Lines and Human Primary CD4+ T-Cells.人类免疫缺陷病毒 1 优先与细胞系和人源初始 CD4+T 细胞中的 pH 中性内吞小泡融合。
ACS Nano. 2023 Sep 12;17(17):17436-17450. doi: 10.1021/acsnano.3c05508. Epub 2023 Aug 17.
Zotero 插件